Ori Biotech Ltd.. (12/15/22). "Press Release: Ori Biotech and Inceptor Bio Partner to Accelerate Solid Tumor Cell Therapy Access". London & Morrisville, NC. |
2022-12-15 |
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. |
2022-12-15 |
Transgene S.A.. (12/15/22). "Press Release: Transgene Announces Upcoming Investor Meetings". Strasbourg. |
2022-12-15 |
PhoreMost Ltd.. (12/14/22). "Press Release: PhoreMost and ThinkCyte Collaborate to Advance AI Based Drug Discovery". Cambridge. |
2022-12-14 |
PrecisionLife Ltd.. (12/14/22). "Press Release: PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical". Oxford. |
2022-12-14 |
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. |
2022-12-14 |
Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford. |
2022-12-14 |
Corbion N.V.. (12/13/22). "Press Release: Corbion Appoints Jennifer Lindsey as Chief Marketing and Digital Officer". |
2022-12-13 |
BehaVR, Inc.. (12/13/22). "Press Release: BehaVR and OxfordVR Combine and Raise Series B to Create Largest VR Delivery Platform for Evidence-Based Digital Therapeutics". Nashville, TN & Oxford. |
2022-12-13 |
Green Bioactives Ltd.. (12/13/22). "Press Release: Green Bioactives Completes £2.6m Seed Financing to Advance Its Sustainable Plant Products Biomanufacturing Platform". Edinburgh. |
2022-12-13 |
Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA. |
2022-12-12 |
Genedata AG. (12/12/22). "Press Release: Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery". Basel. |
2022-12-12 |
Novozymes A/S. (12/12/22). "Press Release: Novozymes and Chr. Hansen to Combine and Create a Leading Global Biosolutions Partner [Not for US, CA, et al.]". Copenhagen. |
2022-12-12 |
MicrofluidX Ltd.. (12/8/22). "Press Release: MicrofluidX Raises £3.3 Million to Develop Their Next Generation Advanced Therapy Manufacturing Platform". Stevenage. |
2022-12-08 |
Sartorius AG. (12/8/22). "Press Release: Sartorius Agrees with Bico on Strategic Cooperation as well as a 10 Percent Capital Investment". Göttingen. |
2022-12-08 |
Oncopeptides AB. (12/7/22). "Press Release: Oncopeptides Provides Update on Pepaxto US Marketing Authorization". Stockholm. |
2022-12-07 |
Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff. |
2022-12-06 |
Coulter Partners. (12/6/22). "Press Release: Coulter Partners Appoints Dr. Hannah Musisi as Executive Director". |
2022-12-06 |
Touchlight Genetics Ltd.. (11/29/22). "Press Release: Touchlight Receives Grant to Advance Rapid, Scalable and Thermostable doggybone DNA Vaccine Platform". Hampton. |
2022-11-29 |
AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy". |
2022-11-29 |
Rarity Bioscience AB. (11/29/22). "Press Release: Rarity Bioscience Raises €2.5M in Seed Funding to Improve Cancer Care". Uppsala. |
2022-11-29 |
V7 Ltd.. (11/28/22). "Press Release: V7 Raises a $33m Series A to Help Teams Build Robust AI, Faster". London. |
2022-11-28 |
Hemispherian AS. (11/24/22). "Press Release: Hemispherian Raises the First Tranche of a Series A to Fund the Development of Its Novel Cancer Therapeutics". Oslo. |
2022-11-24 |
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. |
2022-11-22 |
Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. |
2022-11-22 |
Novo Nordisk A/S. (11/22/22). "Press Release: Novo Nordisk Invests DKK 5.4 bn Danish Kroner in Expansion of Clinical Manufacturing Facilities in Bagsværd, Denmark". Bagsværd. |
2022-11-22 |
Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. |
2022-11-21 |
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". |
2022-11-17 |
Touchlight Genetics Ltd.. (11/15/22). "Press Release: Touchlight Signs License Agreement with Voyager for Use of Touchlight’s DNA Technology in Voyager’s Capsid Discovery Platform". Hampton. |
2022-11-15 |
NRG Therapeutics Ltd.. (11/9/22). "Press Release: NRG Therapeutics Announces £16 Million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS". Stevenage. |
2022-11-09 |
Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford. |
2022-11-08 |
PrecisionLife Ltd.. (11/8/22). "Press Release: PrecisionLife to Evaluate Precision Medicine Potential of Sosei Heptares Neuroscience GPCR Target". |
2022-11-08 |
VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam. |
2022-11-08 |
Ubiquigent Ltd.. (11/7/22). "Press Release: Ubiquigent Appoints Dr Hozefa Amijee as Head of Business Development". Dundee. |
2022-11-07 |
OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. |
2022-11-07 |
Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. |
2022-11-07 |
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. |
2022-11-03 |
Norstella. (11/1/22). "Press Release: Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company". |
2022-11-01 |
Exscientia plc. (11/1/22). "Press Release: Exscientia to Present at Upcoming Investor Conferences in November". Oxford. |
2022-11-01 |
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. |
2022-11-01 |
Eagle Genomics Ltd.. (10/31/22). "Press Release: Eagle Genomics Announces USD 20M First Close, Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation". Cambridge. |
2022-10-31 |
Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA. |
2022-10-31 |
PhoreMost Ltd.. (10/28/22). "Press Release: PhoreMost Enters Multi-target Collaboration with Targeted Protein Degradation Leader Arvinas". Cambridge. |
2022-10-28 |
MorphoSys AG. (10/27/22). "Press Release: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis". Planegg. |
2022-10-27 |
Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". |
2022-10-26 |
Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried. |
2022-10-25 |
Adaptimmune Therapeutics plc. (10/25/22). "Press Release: Adaptimmune Enhances Its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK". Philadelphia, PA & Oxford. |
2022-10-25 |
Green Bioactives Ltd.. (10/24/22). "Press Release: Green Bioactives Appoints David McElroy as CEO ". Edinburgh. |
2022-10-24 |
AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. |
2022-10-20 |
FyoniBio GmbH. (10/20/22). "Press Release: FyoniBio and Strike Pharma Sign a Master Service Agreement Covering Cell Line Development for a Novel Bi-specific Therapeutic mAb". Berlin & Stockholm. |
2022-10-20 |
Enhanc3D Genomics Ltd.. (10/20/22). "Press Release: Enhanc3D Genomics Raises £10 Million in Series A Financing to Advance GenLink3D Proprietary Technology Platform". Cambridge. |
2022-10-20 |
Hemispherian AS. (10/19/22). "Press Release: Hemispherian Secures EUR 10M in Financing from the European Innovation Council (EIC) Accelerator Program". Oslo. |
2022-10-19 |
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. |
2022-10-19 |
Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. |
2022-10-18 |
GSK plc. (10/18/22). "Press Release: GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D". London. |
2022-10-18 |
Clinical Microbiomics A/S. (10/17/22). "Press Release: Clinical Microbiomics Acquire MS-Omics to Become Leading Multi-omics Provider for the Microbiome field". Copenhagen. |
2022-10-17 |
PBD Biotech Ltd.. (10/17/22). "Press Release: PBD Biotech Raises further £2.4m for Its Breakthrough Tuberculosis Blood Test". |
2022-10-17 |
Innovation Zero. (10/17/22). "Press Release: Major Climate and Cleantech Congress Announces First International Trade and Innovation Keynote Speakers". London. |
2022-10-17 |
Illumina, Inc.. (10/11/22). "Press Release: Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery". San Diego, CA. |
2022-10-11 |
Seventure Partners. (10/11/22). "Press Release: Clinical Microbiomics Set to Accelerate Its Expansion with EUR 10 Million Investment from Health for Life Capital II Managed by Seventure Partners". Paris & Copenhagen. |
2022-10-11 |
Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition". |
2022-10-06 |
Coulter Partners. (10/6/22). "Press Release: Coulter Partners and Differing Minds Announce Partnership Agreement". |
2022-10-06 |
Araris Biotech AG. (10/4/22). "Press Release: Araris Biotech Closes $24 Million Financing Round". Zurich. |
2022-10-04 |
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. |
2022-09-30 |
Ventus Therapeutics, Inc.. (9/29/22). "Press Release: Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program". Waltham, MA & Montréal, QC. |
2022-09-29 |
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". |
2022-09-29 |
Pheon Therapeutics Ltd.. (9/28/22). "Press Release: Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors". London. |
2022-09-28 |
GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. |
2022-09-22 |
Biovian Oy. (9/22/22). "Press Release: Biovian Announces the Appointment of a New Board Member. Dr. Uwe Gottschalk Has Joined Biovian’s Board of Directors". |
2022-09-22 |
Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". |
2022-09-21 |
Onego Bio Ltd.. (9/20/22). "Press Release: Perfect Day Deepens Investment in Enterprise Biology Business with New Brand Identity, nth Bio, and Announces Partnership with Onego Bio". Salt Lake City, UT. |
2022-09-20 |
Gilead Sciences, Inc.. (9/20/22). "Press Release: Gilead Sciences Completes Acquisition of MiroBio". Foster City, CA. |
2022-09-20 |
Tridek-One SAS. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. |
2022-09-15 |
Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin. |
2022-09-13 |
Ori Biotech Ltd.. (9/13/22). "Press Release: Ori Biotech and CTMC Partner to Accelerate Novel Cell Therapy Delivery". London & Houston, TX. |
2022-09-13 |
Novo Nordisk A/S. (9/12/22). "Press Release: Novo Nordisk and Microsoft Collaborate to Accelerate Drug Discovery and Development Using Big Data and Artificial Intelligence". Bagsværd & Redmond, WA. |
2022-09-12 |
AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. |
2022-09-08 |
MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY. |
2022-09-08 |
Onego Bio Ltd.. (9/7/22). "Press Release: Onego Bio Secures EUR 4.5M Additional Funding to Accelerate Research and Development". Helsinki. |
2022-09-07 |
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Announces Acquisition of Basilea Pharmaceutica’s PARG Inhibitor Programme". Edinburgh. |
2022-09-06 |
PhoreMost Ltd.. (9/6/22). "Press Release: PhoreMost Enters Multi-project Drug Target Discovery Collaboration with Roche". Cambridge. |
2022-09-06 |
Bicycle Therapeutics plc. (9/6/22). "Press Release: Bicycle Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference". Cambridge & Boston, MA. |
2022-09-06 |
Biovian Oy. (9/6/22). "Press Release: Biovian Appoints Its First US-based Business Development Manager". |
2022-09-06 |
Nodus Oncology Ltd.. (9/6/22). "Press Release: Nodus Oncology Launches, Founded by Cumulus Oncology and in Partnership with the Lead Discovery Center, to Focus on Developing First and Best-in-Class Molecules Inhibiting Novel DNA Damage Response Targets". |
2022-09-06 |
Biohit Oyj. (9/2/22). "Press Release: Change of CEO at Biohit Oyj". |
2022-09-02 |
Novo Nordisk A/S. (9/1/22). "Press Release: Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders". Bagsværd & Watertown, MA. |
2022-09-01 |
AH Diagnostics A/S. (9/1/22). "Press Release: AH Diagnostics AS Acquires DiuVita Diagnostics AS". |
2022-09-01 |
Laverock Therapeutics Ltd.. (8/31/22). "Press Release: Laverock Therapeutics Founded to Develop the Next Generation of Programmable Cell Therapies". |
2022-08-31 |
Ori Biotech Ltd.. (8/30/22). "Press Release: Ori Biotech Adds to Senior Team, Scientific Advisory Board and Expands Global Footprint". London. |
2022-08-30 |
Precision Medicine Scotland Innovation Centre (PMS-IC). (8/25/22). "Press Release: Up to £300,000 Available from Precision Medicine Scotland Innovation Centre to Support Researchers across Scotland". Basel. |
2022-08-25 |
Vaderis Therapeutics AG. (8/22/22). "Press Release: Vaderis Therapeutics AG Emerges from Stealth and Announces Initiation of Clinical Proof-of-Concept Trial in HHT". Basel. |
2022-08-22 |
Adelis Equity Partners. (8/22/22). "Press Release: Adelis Equity Partners Raises Fund Continuation Vehicle for SSI Diagnostica Group, Enabling Transformational Acquisition". |
2022-08-22 |
SSI Diagnostica A/S. (8/22/22). "Press Release: SSI Diagnostica Continues Strong Growth Journey by Merging with Virginia-based TechLab". |
2022-08-22 |
BioInnovation Institute (BII). (8/22/22). "Press Release: BII Supports Three International Start-ups Developing Pioneering Science in the Therapeutics and Health Tech Space". |
2022-08-22 |
Rentschler Biopharma SE. (8/18/22). "Press Release: Rentschler Biopharma Appoints Mark Caswell as Vice President, Site Head for US Facility". Laupheim & Milford, MA. |
2022-08-18 |
Constructive Biology Ltd.. (8/15/22). "Press Release: Constructive Bio Launches with $15M Seed Investment to Re-engineer Biology, Creating New Classes of Enzymes, Pharmaceuticals and Biomaterials". Cambridge. |
2022-08-15 |
Medicines Discovery Catapult (MDC). (8/11/22). "Press Release: Medicines Discovery Catapult and Zeiss Set Sights on Advancing Microscopy. Driving the Application of Microscopy in Drug Discovery". |
2022-08-11 |
PsiOxus Therapeutics Ltd.. (8/11/22). "Press Release: PsiOxus Therapeutics Appoints Howard Davis, Ph.D. as Chief Executive Officer". Oxford. |
2022-08-11 |
Evitria AG. (8/8/22). "Press Release: Genovis AB Enters Service Agreement with Evitria AG for Fast LC-MS Analysis of Recombinant Antibodies". |
2022-08-08 |
Sartorius AG. (8/8/22). "Press Release: Sartorius to Acquire Albumedix, Strengthening Its Portfolio of Innovative Advanced Therapy Solutions". Göttingen. |
2022-08-08 |